يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA

    المؤلفون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    المساهمون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    مصطلحات موضوعية: Adalimumab, Adult, Antirheumatic Agent, Etanercept, Female, Human, Infection, Infliximab, Italy, Male, Middle Aged, Registrie, Spondylarthropathie, Surveys and Questionnaire, Tumor Necrosis Factor-alpha

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30767865; info:eu-repo/semantics/altIdentifier/wos/WOS:000473242000017; volume:37; issue:4; firstpage:649; lastpage:655; numberofpages:7; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11577/3308919Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069269152

    الإتاحة: http://hdl.handle.net/11577/3308919Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA

    المؤلفون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    المساهمون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    مصطلحات موضوعية: Adalimumab, Adult, Antirheumatic Agent, Etanercept, Female, Human, Infection, Infliximab, Italy, Male, Middle Aged, Registrie, Spondylarthropathie, Surveys and Questionnaire, Tumor Necrosis Factor-alpha

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30767865; info:eu-repo/semantics/altIdentifier/wos/WOS:000473242000017; volume:37; issue:4; firstpage:649; lastpage:655; numberofpages:7; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11570/3151497Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069269152

    الإتاحة: http://hdl.handle.net/11570/3151497Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: adalimumab, rheumatoid arthritis

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; https://hdl.handle.net/11381/2977213Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: https://hdl.handle.net/11381/2977213Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, CANTARINI, LUCA, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: Adalimumab, Adrenal Cortex Hormone, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Drug Therapy, Combination, Female, Human, Italy, Male, Methotrexate, Middle Aged, Remission Induction, Severity of Illness Index, Treatment Failure, Registries

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660-665; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11577/3277129Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: http://hdl.handle.net/11577/3277129Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto, Bergossi, Francesca, SEBASTIANI, Marco

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: adalimumab, rheumatoid arthritis

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11380/1138097Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: http://hdl.handle.net/11380/1138097Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: Adalimumab, Adrenal Cortex Hormone, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Drug Therapy, Combination, Female, Human, Italy, Male, Methotrexate, Middle Aged, Remission Induction, Severity of Illness Index, Treatment Failure, Registries

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11570/3125611Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: http://hdl.handle.net/11570/3125611Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, GOVONI, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: anti-TNF, rheumatoid arthritis, adalimumab, efficacy

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11392/2373741Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: http://hdl.handle.net/11392/2373741Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, GOVONI, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: anti-TNF, rheumatoid arthritis, adalimumab, efficacy

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11392/2373741Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468

    الإتاحة: http://hdl.handle.net/11392/2373741Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: Experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: Adalimumab, HAQ, Remission, Rheumatoid arthriti, Rheumatology, Immunology and Allergy, Immunology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11586/219636Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468; http://www.clinexprheumatol.org/article.asp?a=10987Test

    الإتاحة: http://hdl.handle.net/11586/219636Test
    http://www.clinexprheumatol.org/article.asp?a=10987Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, SEBASTIANI, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthriti, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; https://hdl.handle.net/11381/2977650Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    https://hdl.handle.net/11381/2977650Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث